Strategies for overcoming the lung surfactant barrier and achieving success in antimicrobial photodynamic therapy

The impressive increase in antimicrobial resistance has required the development of alternative treatments that act on multiple non-specific molecular targets and are effective against a broad range of microorganisms. Antimicrobial Photodynamic Therapy (aPDT) is based on microbial inactivation from...

Full description

Saved in:
Bibliographic Details
Main Authors: Isabelle Almeida de Lima, Lorraine Gabriele Fiuza, Johan Sebastián Díaz Tovar, Dianeth Sara Lima Bejar, Ana Julia Barbosa Tomé, Michelle Barreto Requena, Layla Pires, Gang Zheng, Natalia Mayumi Inada, Cristina Kurachi, Vanderlei Salvador Bagnato
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Journal of Photochemistry and Photobiology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666469024000277
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846150111436996608
author Isabelle Almeida de Lima
Lorraine Gabriele Fiuza
Johan Sebastián Díaz Tovar
Dianeth Sara Lima Bejar
Ana Julia Barbosa Tomé
Michelle Barreto Requena
Layla Pires
Gang Zheng
Natalia Mayumi Inada
Cristina Kurachi
Vanderlei Salvador Bagnato
author_facet Isabelle Almeida de Lima
Lorraine Gabriele Fiuza
Johan Sebastián Díaz Tovar
Dianeth Sara Lima Bejar
Ana Julia Barbosa Tomé
Michelle Barreto Requena
Layla Pires
Gang Zheng
Natalia Mayumi Inada
Cristina Kurachi
Vanderlei Salvador Bagnato
author_sort Isabelle Almeida de Lima
collection DOAJ
description The impressive increase in antimicrobial resistance has required the development of alternative treatments that act on multiple non-specific molecular targets and are effective against a broad range of microorganisms. Antimicrobial Photodynamic Therapy (aPDT) is based on microbial inactivation from oxidative stress and represents an important tool for inactivating microorganisms with low risk of resistance selection. Therefore, our research group has been devoted to demonstrating its effectiveness against pathogens that cause pneumonia, one of the most lethal infections worldwide. Previous studies reported the efficiency and safety of an in vitro photoinactivation protocol for Streptococcus pneumoniae and the delivery of infrared light (external illumination) and photosensitizer (PS) in an animal model. However, the in vivo inactivation of microorganisms still poses challenges due to the presence of lung surfactant (LS), which traps PSs, preventing them from reaching the microbial target. This study investigated different approaches such as use of emulsifiers, perfluorocarbon, oxygen nanobubbles, and copolymer towards overcoming LS and optimizing aPDT response. The most promising strategy consisted in combining indocyanine green (ICG) with GantrezTM AN-139 - a Polyvinyl Methyl Ether/Maleic Anhydride copolymer (PVM/MA) – showing high microbial inactivation and safety for human lung epithelial (A549) and fibroblast (MRC-9) cell lines. The in vitro experiments provided an alternative to overcome the limited PS distribution through LS and will serve as the basis for in vivo studies.
format Article
id doaj-art-87744e4b05594dfeb713eb3e3f1a0706
institution Kabale University
issn 2666-4690
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Journal of Photochemistry and Photobiology
spelling doaj-art-87744e4b05594dfeb713eb3e3f1a07062024-11-29T06:25:15ZengElsevierJournal of Photochemistry and Photobiology2666-46902024-12-0124100252Strategies for overcoming the lung surfactant barrier and achieving success in antimicrobial photodynamic therapyIsabelle Almeida de Lima0Lorraine Gabriele Fiuza1Johan Sebastián Díaz Tovar2Dianeth Sara Lima Bejar3Ana Julia Barbosa Tomé4Michelle Barreto Requena5Layla Pires6Gang Zheng7Natalia Mayumi Inada8Cristina Kurachi9Vanderlei Salvador Bagnato10São Carlos Institute of Physics, University of São Paulo, São Carlos, SP, Brazil; Corresponding author.São Carlos Institute of Physics, University of São Paulo, São Carlos, SP, BrazilSão Carlos Institute of Physics, University of São Paulo, São Carlos, SP, BrazilSão Carlos Institute of Physics, University of São Paulo, São Carlos, SP, BrazilSão Carlos Institute of Physics, University of São Paulo, São Carlos, SP, BrazilSão Carlos Institute of Physics, University of São Paulo, São Carlos, SP, Brazil; Department of Biomedical Engineering, Texas A&M University, USAPrincess Margaret Cancer Centre, University Health Network, Toronto, CanadaPrincess Margaret Cancer Centre, University Health Network, Toronto, CanadaSão Carlos Institute of Physics, University of São Paulo, São Carlos, SP, BrazilSão Carlos Institute of Physics, University of São Paulo, São Carlos, SP, BrazilSão Carlos Institute of Physics, University of São Paulo, São Carlos, SP, Brazil; Department of Biomedical Engineering, Texas A&M University, USAThe impressive increase in antimicrobial resistance has required the development of alternative treatments that act on multiple non-specific molecular targets and are effective against a broad range of microorganisms. Antimicrobial Photodynamic Therapy (aPDT) is based on microbial inactivation from oxidative stress and represents an important tool for inactivating microorganisms with low risk of resistance selection. Therefore, our research group has been devoted to demonstrating its effectiveness against pathogens that cause pneumonia, one of the most lethal infections worldwide. Previous studies reported the efficiency and safety of an in vitro photoinactivation protocol for Streptococcus pneumoniae and the delivery of infrared light (external illumination) and photosensitizer (PS) in an animal model. However, the in vivo inactivation of microorganisms still poses challenges due to the presence of lung surfactant (LS), which traps PSs, preventing them from reaching the microbial target. This study investigated different approaches such as use of emulsifiers, perfluorocarbon, oxygen nanobubbles, and copolymer towards overcoming LS and optimizing aPDT response. The most promising strategy consisted in combining indocyanine green (ICG) with GantrezTM AN-139 - a Polyvinyl Methyl Ether/Maleic Anhydride copolymer (PVM/MA) – showing high microbial inactivation and safety for human lung epithelial (A549) and fibroblast (MRC-9) cell lines. The in vitro experiments provided an alternative to overcome the limited PS distribution through LS and will serve as the basis for in vivo studies.http://www.sciencedirect.com/science/article/pii/S2666469024000277PneumoniaLung surfactantIndocyanine greenInfrared lightAntimicrobial photodynamic therapy
spellingShingle Isabelle Almeida de Lima
Lorraine Gabriele Fiuza
Johan Sebastián Díaz Tovar
Dianeth Sara Lima Bejar
Ana Julia Barbosa Tomé
Michelle Barreto Requena
Layla Pires
Gang Zheng
Natalia Mayumi Inada
Cristina Kurachi
Vanderlei Salvador Bagnato
Strategies for overcoming the lung surfactant barrier and achieving success in antimicrobial photodynamic therapy
Journal of Photochemistry and Photobiology
Pneumonia
Lung surfactant
Indocyanine green
Infrared light
Antimicrobial photodynamic therapy
title Strategies for overcoming the lung surfactant barrier and achieving success in antimicrobial photodynamic therapy
title_full Strategies for overcoming the lung surfactant barrier and achieving success in antimicrobial photodynamic therapy
title_fullStr Strategies for overcoming the lung surfactant barrier and achieving success in antimicrobial photodynamic therapy
title_full_unstemmed Strategies for overcoming the lung surfactant barrier and achieving success in antimicrobial photodynamic therapy
title_short Strategies for overcoming the lung surfactant barrier and achieving success in antimicrobial photodynamic therapy
title_sort strategies for overcoming the lung surfactant barrier and achieving success in antimicrobial photodynamic therapy
topic Pneumonia
Lung surfactant
Indocyanine green
Infrared light
Antimicrobial photodynamic therapy
url http://www.sciencedirect.com/science/article/pii/S2666469024000277
work_keys_str_mv AT isabellealmeidadelima strategiesforovercomingthelungsurfactantbarrierandachievingsuccessinantimicrobialphotodynamictherapy
AT lorrainegabrielefiuza strategiesforovercomingthelungsurfactantbarrierandachievingsuccessinantimicrobialphotodynamictherapy
AT johansebastiandiaztovar strategiesforovercomingthelungsurfactantbarrierandachievingsuccessinantimicrobialphotodynamictherapy
AT dianethsaralimabejar strategiesforovercomingthelungsurfactantbarrierandachievingsuccessinantimicrobialphotodynamictherapy
AT anajuliabarbosatome strategiesforovercomingthelungsurfactantbarrierandachievingsuccessinantimicrobialphotodynamictherapy
AT michellebarretorequena strategiesforovercomingthelungsurfactantbarrierandachievingsuccessinantimicrobialphotodynamictherapy
AT laylapires strategiesforovercomingthelungsurfactantbarrierandachievingsuccessinantimicrobialphotodynamictherapy
AT gangzheng strategiesforovercomingthelungsurfactantbarrierandachievingsuccessinantimicrobialphotodynamictherapy
AT nataliamayumiinada strategiesforovercomingthelungsurfactantbarrierandachievingsuccessinantimicrobialphotodynamictherapy
AT cristinakurachi strategiesforovercomingthelungsurfactantbarrierandachievingsuccessinantimicrobialphotodynamictherapy
AT vanderleisalvadorbagnato strategiesforovercomingthelungsurfactantbarrierandachievingsuccessinantimicrobialphotodynamictherapy